{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T06:15:58Z","timestamp":1783836958435,"version":"3.55.0"},"reference-count":64,"publisher":"Bentham Science Publishers Ltd.","issue":"4","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>The World Health Organization catalogues illnesses such as Chagas disease\nas neglected diseases, due to the low investment in new drugs to fight them. The search for novel and\nnon-side effects anti-parasitic compounds is one of the urgent needs of the Third World. The use of\ntriazolopyrimidines and their metal complexes have demonstrated hopeful results in this field.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>This work studies the antiparasitic efficacy against Trypanosoma cruzi strains of a series\nof zinc triazolopyrimidine complexes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p>A series of Zn complexes has been synthesized by the reaction between the triazolopyrimidine\nderivatives 7-amino-1,2,4-triazolo[1,5-a]pyrimidine (7atp) and 5,7-dimethyl-1,2,4-triazolo[1,5-\na]pyrimidine (dmtp) with Zn(SO4) \u00b7 7H2O, ZnCl2, and Zn(NO3)2 \u00b7 6H2O salts. The complexes have\nbeen analyzed by spectroscopic and thermal assays and X-ray diffraction methods have been used to\ndilucidate the crystalline structure of one of them. The antiparasitic efficacy was tested in vitro\nagainst Trypanosoma cruzi to compare the trypanocidal effect of different ligands and counteranions\nto fight Chagas disease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>The efficacy of these compounds against Trypanosoma cruzi has also been tested to compare\nthe influence of different ligands and counteranions on the trypanocidal effect against Chagas\ndisease.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Antiproliferative tests corroborate the synergistic trypanocidal effect of the triazolopyrimidine\ncoordination complexes.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406417666210812162500","type":"journal-article","created":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T09:38:52Z","timestamp":1628847532000},"page":"444-451","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Zinc 1,2,4-triazolo[1,5-a]pyrimidine Complexes: Synthesis, Structural\nCharacterization and their Effect Against Chagas Disease"],"prefix":"10.2174","volume":"18","author":[{"given":"Jos\u00e9 M.","family":"M\u00e9ndez-Arriaga","sequence":"first","affiliation":[{"name":"Departamento de Biolog\u00eda y Geolog\u00eda, F\u00edsica y Qu\u00edmica Inorganica, Universidad Rey Juan Carlos, c\/Tulip\u00e1n s\/n\n28933, M\u00f3stoles, Madrid, Spain"},{"name":"Departamento de Parasitolog\u00eda, Universidad de Granada, Avda. Fuentenueva s\/n,\n18071 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Rubio-Mirallas","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica Inorg\u00e1nica, Universidad de Granada, Avda. Fuentenueva s\/n,\n18071 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Quir\u00f3s","sequence":"additional","affiliation":[{"name":"Departamento de Qu\u00edmica Inorg\u00e1nica, Universidad de Granada, Avda. Fuentenueva s\/n,\n18071 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"S\u00e1nchez-Moreno","sequence":"additional","affiliation":[{"name":"Departamento de Parasitolog\u00eda, Universidad de Granada, Avda. Fuentenueva s\/n,\n18071 Granada, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1002\/cber.19090420468","volume":"42","author":"Bulow C.","year":"1909","unstructured":"Bulow C.; Haas K.; Synthetische versuche zur darstellung von derivaten des heterokondensierten, heterocyclischen 1.3\u2010Triazo\u20107.0\u2032\u2010pyrimidins. Chem Ber 1909,42,4638-4644","journal-title":"Chem Ber"},{"key":"ref=2","first-page":"2","volume":"47","year":"1952","unstructured":"Birr. Z Wiss Photogr Photophys Photochem 1952,47,2-27","journal-title":"Z Wiss Photogr Photophys Photochem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0065-2725(07)95003-5","volume":"95","author":"Fischer G.","year":"2008","unstructured":"Fischer G.; Recent progress in 1,2,4-triazolo[1,5-a]pyrimidine chemistry. Adv Heterocycl Chem 2008,95,143-219","journal-title":"Adv Heterocycl Chem"},{"key":"ref=4","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.102919","volume":"88","author":"Singh P.K.","year":"2019","unstructured":"Singh P.K.; Choudhary S.; Kashyap A.; Verma H.; Kapil S.; Kumar M.; Arora M.; Silakari O.; An exhaustive compilation on chemistry of triazolopyrimidine: A journey through decades. Bioorg Chem 2019,88","journal-title":"Bioorg Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"o1509","DOI":"10.1107\/S1600536807008641","volume":"63","author":"Maldonado C.R.","year":"2007","unstructured":"Maldonado C.R.; Quir\u00f3s M.; Salas J.M.; 1,2,4-triazolo[1,5-a]pyrimidin-3-ium chloride. Acta Crystallogr Sect E Struct Rep Online 2007,63(3),o1509-o1510","journal-title":"Acta Crystallogr Sect E Struct Rep Online"},{"key":"ref=6","first-page":"o1310","volume":"62","author":"Odabasoglu M.","year":"2002","unstructured":"Odabasoglu M.; B\u00fcy\u00fckg\u00fcng\u00f6r O.; 5,7-dimethyl-1,2,4-triazolo[1,5- a ]pyrimidine. Acta Crystallogr 2002,62,o1310-o1311","journal-title":"Acta Crystallogr"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1039\/C1DT11385B","volume":"41","author":"Caballero A.B.","year":"2012","unstructured":"Caballero A.B.; Rodr\u00edguez-Di\u00e9guez A.; Vidal I.; Dobado J.A.; Castillo \u00d3.; Lezama L.; Salas J.M.; Insights on the binding ability of a new adenine analog: 7-amine-1,2,4-triazolo[1,5-a]pyrimidine. Synthesis and magnetic study of the first copper(II) complexes. Dalton Trans 2012,41(6),1755-1764","journal-title":"Dalton Trans"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0022-2860(99)00303-8","volume":"519","author":"Abul Haj M.","year":"2000","unstructured":"Abul Haj M.; Salas J.M.; Quir\u00f3s M.; Molina J.; Faure R.; 5-oxo and 7-oxo derivatives of [1,2,4]triazolo-[1,5-a]pyrimidine: characterization and theoretical study. J Mol Struct 2000,519,165-172","journal-title":"J Mol Struct"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1039\/a700888k","author":"Navarro J.A.R.","year":"1997","unstructured":"Navarro J.A.R.; Romero M.A.; Salas J.M.; Faure R.; Solans X.; Polymeric silver(I) complexes of the multinucleating ligand 4,7-dihydro-5-methyl-7-oxo(1,2,4)triazolo(1,5-alpha)pyrimidine -analogous hydrogen-bonded structures in the crystal and vapor-phases of the ligand. J Chem Soc, Dalton Trans 1997,2321-2326","journal-title":"J Chem Soc, Dalton Trans"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jinorgbio.2017.07.026","volume":"175","author":"M\u00e9ndez-Arriaga J.M.","year":"2017","unstructured":"M\u00e9ndez-Arriaga J.M.; Esteban-Parra G.M.; Ju\u00e1rez M.J.; Rodr\u00edguez-Di\u00e9guez A.; S\u00e1nchez-Moreno M.; Isac-Garc\u00eda J.; Salas J.M.; Antiparasitic activity against trypanosomatid diseases and novel metal complexes derived from the first time characterized 5-phenyl-1,2,4-triazolo[1,5-a]pyrimidi-7(4H)-one. J Inorg Biochem 2017,175,217-224","journal-title":"J Inorg Biochem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jinorgbio.2014.03.009","volume":"136","author":"Barbosa M.I.F.","year":"2014","unstructured":"Barbosa M.I.F.; Corr\u00eaa R.S.; de Oliveira K.M.; Rodrigues C.; Ellena J.; Nascimento O.R.; Rocha V.P.C.; Nonato F.R.; Macedo T.S.; Barbosa-Filho J.M.; Soares M.B.; Batista A.A.; Antiparasitic activities of novel ruthenium\/lapachol complexes. J Inorg Biochem 2014,136,33-39","journal-title":"J Inorg Biochem"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jinorgbio.2017.01.011","volume":"170","author":"Rodr\u00edguez Arce E.","year":"2017","unstructured":"Rodr\u00edguez Arce E.; Machado I.; Rodr\u00edguez B.; Lapier M.; Z\u00fa\u00f1iga M.C.; Maya J.D.; Olea Azar C.; Otero L.; Gambino D.; Rhenium(I) tricarbonyl compounds of bioactive thiosemicarbazones: Synthesis, characterization and activity against Trypanosoma cruzi. J Inorg Biochem 2017,170,125-133","journal-title":"J Inorg Biochem"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.jinorgbio.2017.08.018","volume":"176","author":"Fandzloch M.","year":"2017","unstructured":"Fandzloch M.; Arriaga J.M.M.; S\u00e1nchez-Moreno M.; Wojtczak A.; Jezierska J.; Sitkowski J.; Wi\u015bniewska J.; Salas J.M.; \u0141akomska I.; Strategies for overcoming tropical disease by ruthenium complexes with purine analog: Application against Leishmania spp. and Trypanosoma cruzi. J Inorg Biochem 2017,176,144-155","journal-title":"J Inorg Biochem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/ejic.201901119","volume":"2020","author":"Esteban\u2010Parra G.M.","year":"2020","unstructured":"Esteban\u2010Parra G.M.; Moscoso I.; Cepeda, J.; Garc\u00eda, J.A.; S\u00e1nchez\u2010Moreno, S.; Rodr\u00edguez\u2010Di\u00e9guez, A.; Quir\u00f3s, M. Lanthanide(III) based complexes containing 5,7\u2010dimethyl\u20101,2,4\u2010triazolo[1,5\u2010a]pyrimidine as long\u2010lived photoluminescent antiparasitic agents. Eur J Inorg Chem 2020,2020(3),308-317","journal-title":"Eur J Inorg Chem"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jinorgbio.2015.06.007","volume":"150","author":"Miserachs H.G.","year":"2015","unstructured":"Miserachs H.G.; Cipriani M.; Grau J.; Vilaseca M.; Lorenzo J.; Medeiros A.; Comini M.A.; Gambino D.; Otero L.; Moreno V.; Antitumor and antiparasitic activity of novel ruthenium compounds with polycyclic aromatic ligands. J Inorg Biochem 2015,150,38-47","journal-title":"J Inorg Biochem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"S1345","DOI":"10.1016\/j.arabjc.2013.04.002","volume":"10","author":"Hassan G.S.","year":"2017","unstructured":"Hassan G.S.; El-Sherbeny M.A.; El-Ashmawy M.B.; Bayomi S.M.; Maarouf A.R.; Badria F.A.; Synthesis and antitumor testing of certain new fused triazolopyrimidine and triazoloquinazoline derivatives. Arab J Chem 2017,10,S1345-S1355","journal-title":"Arab J Chem"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1128\/AAC.00410-16","volume":"60","author":"Rice D.R.","year":"2016","unstructured":"Rice D.R.; Vacchina P.; Norris-Mullins B.; Morales M.A.; Smith B.D.; Zinc(II)-dipicolylamine coordination complexes as targeting and chemotherapeutic agents for Leishmania major. Antimicrob Agents Chemother 2016,60(5),2932-2940","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"14453","DOI":"10.1039\/C5DT00557D","volume":"44","author":"Rodr\u00edguez Arce E.","year":"2015","unstructured":"Rodr\u00edguez Arce E.; Mosquillo M.F.; P\u00e9rez-D\u00edaz L.; Echeverr\u00eda G.A.; Piro O.E.; Merlino A.; Coiti\u00f1o E.L.; Mar\u00edngolo Ribeiro C.; Leite C.Q.F.; Pavan F.R.; Otero L.; Gambino D.; Aromatic amine N-oxide organometallic compounds: searching for prospective agents against infectious diseases. Dalton Trans 2015,44(32),14453-14464","journal-title":"Dalton Trans"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/j.ccr.2010.12.028","volume":"255","author":"Gambino D.","year":"2011","unstructured":"Gambino D.; Potentiality of vanadium compounds as anti-parasitic agents. Coord Chem Rev 2011,255(19),2193-2203","journal-title":"Coord Chem Rev"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ccr.2016.04.014","volume":"327-328","author":"\u0141akomska I.","year":"2016","unstructured":"\u0141akomska I.; Fandzloch M.; Application of 1,2,4-triazolo[1,5-a]pyrimidines for the design of coordination compounds with interesting structures and new biological properties. Coord Chem Rev 2016,327-328,221-241","journal-title":"Coord Chem Rev"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/S0010-8545(99)00004-1","volume":"195","author":"Salas J.M.","year":"1999","unstructured":"Salas J.M.; Romero M.A.; S\u00e1nchez M.P.; Quir\u00f3s M.; Metal complexes of [1,2,4]triazolo-[1,5-a]pyrimidine derivatives. Coord Chem Rev 1999,195,1119-1142","journal-title":"Coord Chem Rev"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.2174\/0929867324666170516122024","volume":"24","author":"Salas J.M.","year":"2017","unstructured":"Salas J.M.; Caballero A.B.; Esteban-Parra G.M.; M\u00e9ndez-Arriaga J.M.; Leishmanicidal and trypanocidal activity of metal complexes with 1,2,4-triazolo[1,5-a]pyrimidines: insights on their therapeutic potential against leishmaniasis and chagas disease. Curr Med Chem 2017,24(25),2796-2806","journal-title":"Curr Med Chem"},{"key":"ref=23","unstructured":"Caballero, A.B.; Salas, J.M.; S\u00e1nchez Moreno, M. Metal Based Therapeutics for Leishmaniasis in: Leishmaniasis - Trends in Epidemiology, Diagnosis and Treatment, David M. Claborn, Ed.; Chapter 20, 2014."},{"key":"ref=24","doi-asserted-by":"publisher","DOI":"10.1016\/j.poly.2019.114272","volume":"176","author":"M\u00e9ndez-Arriaga J.M.","year":"2020","unstructured":"M\u00e9ndez-Arriaga J.M.; Rodr\u00edguez-Di\u00e9guez A.; S\u00e1nchez-Moreno M.; In vitro leishmanicidal activity of copper (II) 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine complex and analogous transition metal series. Polyhedron 2020,176","journal-title":"Polyhedron"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"11845","DOI":"10.1039\/c1dt10603a","volume":"40","author":"Caballero A.B.","year":"2011","unstructured":"Caballero A.B.; Maclaren J.K.; Rodr\u00edguez-Di\u00e9guez A.; Vidal I.; Dobado J.A.; Salas J.M.; Janiak C.; Dinuclear silver(I) complexes for the design of metal-ligand networks based on triazolopyrimidines. Dalton Trans 2011,40(44),11845-11855","journal-title":"Dalton Trans"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s10593-016-1816-8","volume":"51","author":"Astakhov A.V.","year":"2016","unstructured":"Astakhov A.V.; Sokolov A.N.; Pyatakov D.A.; Shishkina S.V.; Shishkin O.V.; Chernyshev V.M.; Reactivity of 2-amino[1,2,4]triazolo[1,5-a]-pyrimidines with various saturation of the pyrimidine ring towards electrophiles. Chem Heterocycl Compd 2016,51,1039-1047","journal-title":"Chem Heterocycl Compd"},{"key":"ref=27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinorgbio.2019.110810","volume":"201","author":"Esteban-Parra G.M.","year":"2019","unstructured":"Esteban-Parra G.M.; M\u00e9ndez-Arriaga J.M.; Rodr\u00edguez-Di\u00e9guez A.; Quir\u00f3s M.; Salas J.M.; S\u00e1nchez-Moreno M.; High antiparasitic activity of silver complexes of 5,7-dimethyl-1,2,4-triazolo[1,5 a]pyrimidine. J Inorg Biochem 2019,201","journal-title":"J Inorg Biochem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1021\/jm501831g","volume":"58","author":"Wang H.","year":"2015","unstructured":"Wang H.; Lee M.; Peng Z.; Bl\u00e1zquez B.; Lastochkin E.; Kumarasiri M.; Bouley R.; Chang M.; Mobashery S.; Synthesis and evaluation of 1,2,4-triazolo[1,5-a]pyrimidines as antibacterial agents against Enterococcus faecium. J Med Chem 2015,58(10),4194-4203","journal-title":"J Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2174\/187231209787176317","volume":"3","author":"Boutaleb-Charki S.","year":"2009","unstructured":"Boutaleb-Charki S.; Mar\u00edn C.; Maldonado C.R.; Rosales M.J.; Urbano J.; Guitierrez-S\u00e1nchez R.; Quir\u00f3s M.; Salas J.M.; S\u00e1nchez-Moreno M.; Copper (II) complexes of [1,2,4]triazolo [1,5-a]pyrimidine derivatives as potential anti-parasitic agents. Drug Metab Lett 2009,3(1),35-44","journal-title":"Drug Metab Lett"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jinorgbio.2017.11.027","volume":"180","author":"M\u00e9ndez-Arriaga J.M.","year":"2018","unstructured":"M\u00e9ndez-Arriaga J.M.; Oyarzabal I.; Escolano G.; Rodr\u00edguez-Di\u00e9guez A.; S\u00e1nchez-Moreno M.; Salas J.M.; In vitro leishmanicidal and trypanocidal evaluation and magnetic properties of 7-amino-1,2,4-triazolo[1,5-a]pyrimidine Cu(II) complexes. J Inorg Biochem 2018,180,26-32","journal-title":"J Inorg Biochem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.2174\/1573406415666190401120607","volume":"16","author":"M\u00e9ndez-Arriaga J.M.","year":"2020","unstructured":"M\u00e9ndez-Arriaga J.M.; Oyarzabal I.; Mart\u00edn-Montes \u00c1.; Garc\u00eda-Rodr\u00edguez J.; Quir\u00f3s M.; S\u00e1nchez-Moreno M.; First example of antiparasitic activity influenced by thermochromism: leishmanicidal evaluation of 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine metal complexes. Med Chem 2020,16(3),422-430","journal-title":"Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.ica.2015.12.036","volume":"443","author":"Fandzloch M.","year":"2016","unstructured":"Fandzloch M.; Wojtczak A.; Wis\u0308niewska J.; Stefa\u0144czak K.; Salas J.M.; \u0141akomska I.; Ruthenium(III) complexes with monodentate 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one: Structural characterization, interaction with DNA and proteins. Inorg Chim Acta 2016,443,170-178","journal-title":"Inorg Chim Acta"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-385863-4.00001-0","volume":"75","author":"Weiss L.M.","year":"2011","unstructured":"Weiss L.M.; Tanowitz H.B.; Kirchhoff L.V.; Epidemiology of American Trypanosomiasis (Chagas Disease) In: Chagas Disease, Part A., Chapter 1. Adv Parasitol 2011,75,1-18","journal-title":"Adv Parasitol"},{"key":"ref=34","first-page":"24","volume":"905","year":"2002","unstructured":"WHO Control of Chagas disease. WHO Tech Rep Ser 2002,905,24-28","journal-title":"WHO Tech Rep Ser"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ica.2012.05.028","volume":"393","author":"Gambino D.","year":"2012","unstructured":"Gambino D.; Otero L.; Perspectives on what ruthenium-based compounds could offer in the development of potential antiparasitic drugs. Inorg Chim Acta 2012,393,103-114","journal-title":"Inorg Chim Acta"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1038\/nature09224","volume":"465","author":"Clayton J.","year":"2010","unstructured":"Clayton J.; Chagas disease: pushing through the pipeline. Nature 2010,465(7301),S12-S15","journal-title":"Nature"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMra064142","volume":"357","author":"Hotez P.J.","year":"2007","unstructured":"Hotez P.J.; Molyneux D.H.; Fenwick A.; Kumaresan J.; Sachs S.E.; Sachs J.D.; Savioli L.; Control of neglected tropical diseases. N Engl J Med 2007,357(10),1018-1027","journal-title":"N Engl J Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1172\/JCI33945","volume":"118","author":"Stuart K.","year":"2008","unstructured":"Stuart K.; Brun R.; Croft S.; Fairlamb A.; G\u00fcrtler R.E.; McKerrow J.; Reed S.; Tarleton R.; Kinetoplastids: related protozoan pathogens, different diseases. J Clin Invest 2008,118(4),1301-1310","journal-title":"J Clin Invest"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.pt.2005.08.026","volume":"21","author":"Croft S.L.","year":"2005","unstructured":"Croft S.L.; Barrett M.P.; Urbina J.A.; Chemotherapy of trypanosomiases and leishmaniasis. Trends Parasitol 2005,21(11),508-512","journal-title":"Trends Parasitol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drup.2007.02.004","volume":"10","author":"Delespaux V.","year":"2007","unstructured":"Delespaux V.; de Koning H.P.; Drugs and drug resistance in African trypanosomiasis. Drug Resist Updat 2007,10(1-2),30-50","journal-title":"Drug Resist Updat"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","volume":"115","author":"Urbina J.A.","year":"2010","unstructured":"Urbina J.A.; Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches. Acta Trop 2010,115(1-2),55-68","journal-title":"Acta Trop"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0006-2952(87)90689-7","volume":"36","author":"Berman J.D.","year":"1987","unstructured":"Berman J.D.; Gallalee J.V.; Best J.M.; Sodium stibogluconate (Pentostam) inhibition of glucose catabolism via the glycolytic pathway, and fatty acid beta-oxidation in Leishmania mexicana amastigotes. Biochem Pharmacol 1987,36(2),197-201","journal-title":"Biochem Pharmacol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0304-4017(02)00115-2","volume":"106","author":"Baneth G.","year":"2002","unstructured":"Baneth G.; Shaw S.E.; Chemotherapy of canine Leishmaniosis. Vet Parasitol 2002,106(4),315-324","journal-title":"Vet Parasitol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1046\/j.1365-4362.2002.01527.x","volume":"41","author":"Momeni A.Z.","year":"2002","unstructured":"Momeni A.Z.; Reiszadae M.R.; Aminjavaheri M.; Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate. Int J Dermatol 2002,41(7),441-443","journal-title":"Int J Dermatol"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/MJT.0b013e3181822e90","volume":"16","author":"Palumbo E.","year":"2009","unstructured":"Palumbo E.; Current treatment for cutaneous leishmaniasis: a review. Am J Ther 2009,16(2),178-182","journal-title":"Am J Ther"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.ijantimicag.2007.01.004","volume":"29","author":"Natera S.","year":"2007","unstructured":"Natera S.; Machuca C.; Padr\u00f3n-Nieves M.; Romero A.; D\u00edaz E.; Ponte-Sucre A.; Leishmania spp.: proficiency of drug-resistant parasites. Int J Antimicrob Agents 2007,29(6),637-642","journal-title":"Int J Antimicrob Agents"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","volume":"19","author":"Croft S.L.","year":"2006","unstructured":"Croft S.L.; Sundar S.; Fairlamb A.H.; Drug resistance in leishmaniasis. Clin Microbiol Rev 2006,19(1),111-126","journal-title":"Clin Microbiol Rev"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000074672","volume":"70","author":"Mag\u00e1n R.","year":"2004","unstructured":"Mag\u00e1n R.; Mar\u00edn C.; Rosales M.J.; Barrera M.A.; Salas J.M.; S\u00e1nchez-Moreno M.; Activities of Pt(II) and Ru(III) triazole-pyrimidine complexes against Trypanosoma cruzi and T. brucei brucei. Pharmacology 2004,70(2),83-90","journal-title":"Pharmacology"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"10929","DOI":"10.1021\/acs.jmedchem.6b00784","volume":"59","author":"Moreno-Viguri E.","year":"2016","unstructured":"Moreno-Viguri E.; Jim\u00e9nez-Montes C.; Mart\u00edn-Escolano R.; Santiva\u00f1ez-Veliz M.; Mart\u00edn-Montes A.; Azqueta A.; Jim\u00e9nez-L\u00f3pez M.; Zamora Ledesma S.; Cirauqui N.; L\u00f3pez de Cer\u00e1in A.; Mar\u00edn C.; S\u00e1nchez-Moreno M.; P\u00e9rez-Silanes S.; In vitro and in vivo anti-Trypanosoma cruzi activity of new arylamine Mannich base-type derivatives. J Med Chem 2016,59(24),10929-10945","journal-title":"J Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1016\/j.ejmech.2011.04.054","volume":"46","author":"Plano D.","year":"2011","unstructured":"Plano D.; Baquedano Y.; Moreno-Mateos D.; Font M.; Jim\u00e9nez-Ruiz A.; Palop J.A.; Sanmart\u00edn C.; Selenocyanates and diselenides: a new class of potent antileishmanial agents. Eur J Med Chem 2011,46(8),3315-3323","journal-title":"Eur J Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.2174\/0929867323666161227094049","volume":"24","author":"Beltran-Hortelano I.","year":"2017","unstructured":"Beltran-Hortelano I.; P\u00e9rez-Silanes S.; Galiano S.; Trypanothione reductase and superoxide dismutase as current drug targets for trypanosoma cruzi: an overview of compounds with activity against chagas disease. Curr Med Chem 2017,24(11),1066-1138","journal-title":"Curr Med Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1128\/AAC.02529-15","volume":"60","author":"Baquedano Y.","year":"2016","unstructured":"Baquedano Y.; Alcolea V.; Toro M.A.; Guti\u00e9rrez K.J.; Nguewa P.; Font M.; Moreno E.; Espuelas S.; Jim\u00e9nez-Ruiz A.; Palop J.A.; Plano D.; Sanmart\u00edn C.; Novel heteroaryl selenocyanates and diselenides as potent antileishmanial agents. Antimicrob Agents Chemother 2016,60(6),3802-3812","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"465","DOI":"10.2217\/nnm.14.185","volume":"10","author":"Morilla M.J.","year":"2015","unstructured":"Morilla M.J.; Romero E.L.; Nanomedicines against Chagas disease: an update on therapeutics, prophylaxis and diagnosis. Nanomedicine (Lond) 2015,10(3),465-481","journal-title":"Nanomedicine (Lond)"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.actatropica.2008.08.006","volume":"108","author":"T\u00e9llez-Meneses J.","year":"2008","unstructured":"T\u00e9llez-Meneses J.; Mej\u00eda-Jaramillo A.M.; Triana-Ch\u00e1vez O.; Biological characterization of Trypanosoma cruzi stocks from domestic and sylvatic vectors in Sierra Nevada of Santa Marta, Colombia. Acta Trop 2008,108(1),26-34","journal-title":"Acta Trop"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.ijantimicag.2004.08.010","volume":"25","author":"Gonz\u00e1lez P.","year":"2005","unstructured":"Gonz\u00e1lez P.; Mar\u00edn C.; Rodr\u00edguez-Gonz\u00e1lez I.; Hitos A.B.; Rosales M.J.; Reina M.; D\u00edaz J.G.; Gonz\u00e1lez-Coloma A.; S\u00e1nchez-Moreno M.; In vitro activity of C20-diterpenoid alkaloid derivatives in promastigotes and intracellular amastigotes of Leishmania infantum. Int J Antimicrob Agents 2005,25(2),136-141","journal-title":"Int J Antimicrob Agents"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ejmech.2014.08.026","volume":"85","author":"Caballero A.B.","year":"2014","unstructured":"Caballero A.B.; Rodr\u00edguez-Di\u00e9guez A.; Quir\u00f3s M.; Salas J.M.; Huertas \u00d3.; Ram\u00edrez-Mac\u00edas I.; Olmo F.; Mar\u00edn C.; Chaves-Lemaur G.; Gutierrez-S\u00e1nchez R.; S\u00e1nchez-Moreno M.; Triazolopyrimidine compounds containing first-row transition metals and their activity against the neglected infectious Chagas disease and leishmaniasis. Eur J Med Chem 2014,85,526-534","journal-title":"Eur J Med Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.poly.2011.11.020","volume":"33","author":"Caballero A.B.","year":"2012","unstructured":"Caballero A.B.; Mar\u00edn C.; Ram\u00edrez-Mac\u00edas I.; Rodr\u00edguez-Di\u00e9guez A.; Quir\u00f3s M.; Salas J.M.; S\u00e1nchez-Moreno M.; Structural consequences of the introduction of 2,2\u2032-bipyrimidine as auxiliary ligand in triazolopyrimidine-based transition metal complexes. in vitro antiparasitic activity. Polyhedron 2012,33,137-144","journal-title":"Polyhedron"},{"key":"ref=58","year":"2004","unstructured":"Bruker Apex2; Bruker AXS Inc.: Madison, Wisconsin, USA, 2004.2004"},{"key":"ref=59","author":"Sheldrick G.M.","year":"1996","unstructured":"Sheldrick G.M.;  SADABS, program for empirical adsorption correction, institute for inorganic chemistry 1996","journal-title":"SADABS, program for empirical adsorption correction, institute for inorganic chemistry"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1107\/S2053229614024218","volume":"71","author":"Sheldrick G.M.","year":"2015","unstructured":"Sheldrick G.M.; Crystal structure refinement with SHELXL. Acta Crystallogr C Struct Chem 2015,71(Pt 1),3-8","journal-title":"Acta Crystallogr C Struct Chem"},{"key":"ref=61","first-page":"510","volume":"C50","author":"Salas J.M.","year":"1994","unstructured":"Salas J.M.; Romero M.A.; Rahmani A.; Faure R.; Dichlorobis(5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine-N3)zinc(II). Acta Crystallogr 1994,C50,510-512","journal-title":"Acta Crystallogr"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1016\/S0277-5387(00)83594-9","volume":"11","author":"Salas J.M.","year":"1992","unstructured":"Salas J.M.; Enrique C.; Romero M.A.; Takagi K.; Aoki K.; Miyashita Y.; Suh I.; Synthesis and spectroscopic properties of metal complexes of 5, 7-dimethyl [1, 2, 4] triazolo [1, 5-a] pyrimidine. X-ray structure of the cobalt (II) and cadmium (II) complexes. Polyhedron 1992,11,2903-2912","journal-title":"Polyhedron"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.ica.2010.09.048","volume":"365","author":"Maldonado C.R.","year":"2011","unstructured":"Maldonado C.R.; Quir\u00f3s M.; Salas J.M.; One-dimensional zinc(II) polymers with 4,6-dimethyl-1,2,3-triazolo[4,5-d]pyrimidin-5,7-dionato built by bipyridyl-based ligands acting as spacers both in the first and in the second sphere. Inorg Chim Acta 2011,365(1),371-376","journal-title":"Inorg Chim Acta"},{"key":"ref=64","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2020.105688","volume":"212","author":"De Souza W.","year":"2020","unstructured":"De Souza W.; Barrias E.S.; May the epimastigote form of Trypanosoma cruzi be infective? Acta Trop 2020,212","journal-title":"Acta Trop"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406417666210812162500","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/195612\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406417666210812162500","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T06:47:34Z","timestamp":1666939654000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/195612\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406417666210812162500","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-09-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-30","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}